Lantheus Holdings, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Lantheus Holdings, Inc. (LNTH) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $20.01 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- Lantheus Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $20.01M, a 10.37% decline year-over-year.
- Lantheus Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $16.04M, a 24.33% decline year-over-year.
- Lantheus Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $24.50M, a 20.30% increase year-over-year.
- Lantheus Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $22.32M, a 20.79% increase year-over-year.
- Lantheus Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $85.56M, a 12.00% increase from fiscal 2024.
- Lantheus Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $76.39M, a 51.25% increase from fiscal 2023.
- Lantheus Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $50.51M, a 72.60% increase from fiscal 2022.
- Lantheus Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $29.26M, a 83.65% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $20.01M 10-Q · filed 2026-08-06 | $36.05M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $16.04M 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $85.56M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $24.50M 10-Q · filed 2025-11-06 | $46.82M derived: sum of 2 quarters · filed 2026-08-06 | $68.02M derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-06-30 | $22.32M 10-Q · filed 2026-08-06 | $43.52M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $21.20M 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $76.39M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $20.37M 10-Q · filed 2025-11-06 | $38.84M derived: sum of 2 quarters · filed 2025-11-06 | $54.23M derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | $18.48M 10-Q · filed 2025-11-06 | $33.86M derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-03-31 | $15.38M 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | $50.51M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $13.98M 10-Q · filed 2024-11-06 | $26.67M derived: sum of 2 quarters · filed 2024-11-06 | $36.34M derived: sum of 3 quarters · filed 2024-11-06 | |
| 2023-06-30 | $12.69M 10-Q · filed 2024-11-06 | $22.36M derived: sum of 2 quarters · filed 2024-11-06 | ||
| 2023-03-31 | $9.67M 10-Q · filed 2024-11-06 | |||
| 2022-12-31 | $29.26M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $8.10M 10-Q · filed 2023-11-02 | $15.52M derived: sum of 2 quarters · filed 2023-11-02 | $21.14M derived: sum of 3 quarters · filed 2023-11-02 | |
| 2022-06-30 | $7.41M 10-Q · filed 2023-11-02 | $13.04M derived: sum of 2 quarters · filed 2023-11-02 | ||
| 2022-03-31 | $5.62M 10-Q · filed 2023-11-02 | |||
| 2021-12-31 | $15.93M 10-K · filed 2024-02-22 | |||
| 2021-09-30 | $3.87M 10-Q · filed 2022-11-03 | $8.46M derived: sum of 2 quarters · filed 2022-11-03 | $11.77M derived: sum of 3 quarters · filed 2022-11-03 | |
| 2021-06-30 | $4.59M 10-Q · filed 2022-11-03 | $7.91M derived: sum of 2 quarters · filed 2022-11-03 | ||
| 2021-03-31 | $3.32M 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | $14.07M 10-K · filed 2023-02-23 | |||
| 2020-09-30 | $3.99M 10-Q · filed 2021-11-04 | $7.38M derived: sum of 2 quarters · filed 2021-11-04 | $10.45M derived: sum of 3 quarters · filed 2021-11-04 | |
| 2020-06-30 | $3.38M 10-Q · filed 2021-11-04 | $6.46M derived: sum of 2 quarters · filed 2021-11-04 | ||
| 2020-03-31 | $3.08M 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $12.49M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $3.42M 10-Q · filed 2020-11-05 | $6.78M derived: sum of 2 quarters · filed 2020-11-05 | $9.50M derived: sum of 3 quarters · filed 2020-11-05 | |
| 2019-06-30 | $3.36M 10-Q · filed 2020-11-05 | $6.08M derived: sum of 2 quarters · filed 2020-11-05 | ||
| 2019-03-31 | $2.72M 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $8.72M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $2.41M 10-Q · filed 2019-10-31 | $4.62M derived: sum of 2 quarters · filed 2019-10-31 | $6.42M derived: sum of 3 quarters · filed 2019-10-31 | |
| 2018-06-30 | $2.22M 10-Q · filed 2019-10-31 | $4.01M derived: sum of 2 quarters · filed 2019-10-31 | ||
| 2018-03-31 | $1.80M 10-Q · filed 2019-10-31 | |||
| 2017-12-31 | $5.93M 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $655.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $1.53M derived: sum of 2 quarters · filed 2019-02-20 | $2.12M derived: sum of 3 quarters · filed 2019-02-20 | $2.52M 10-K · filed 2019-02-20 |
| 2016-09-30 | $877.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $1.46M derived: sum of 2 quarters · filed 2016-11-01 | $1.87M 10-Q · filed 2016-11-01 | $2.35M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $585.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $992.00K 10-Q · filed 2016-08-04 | $1.47M derived: sum of 3 quarters · filed 2018-02-26 | $2.06M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $407.00K 10-Q · filed 2016-05-03 | $885.00K derived: sum of 2 quarters · filed 2018-02-26 | $1.48M derived: sum of 3 quarters · filed 2018-02-26 | |
| 2015-12-31 | $478.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $1.07M derived: sum of 2 quarters · filed 2018-02-26 | $2.00M 10-K · filed 2018-02-26 | |
| 2015-09-30 | $591.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $1.52M 10-Q · filed 2015-11-04 | ||
| 2015-06-30 | $933.00K 10-Q · filed 2015-08-05 | |||
| 2014-12-31 | $1.03M 10-K · filed 2017-02-23 | |||
| 2013-12-31 | $578.00K 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |